Published online Jun 28, 2022. doi: 10.13105/wjma.v10.i3.143
Peer-review started: December 18, 2021
First decision: March 13, 2022
Revised: March 23, 2022
Accepted: June 21, 2022
Article in press: June 21, 2022
Published online: June 28, 2022
Processing time: 199 Days and 8.5 Hours
Platelet-rich plasma has been gaining popularity as an agent for biological augmentation either as the sole treatment modality or as an adjunct to surgical repair.
There is growing evidence on the positive effects of platelet-derived autologous growth factors on collagen production, cell proliferation, tissue revascularization and tendon regeneration thereby making them useful as an augment to arthroscopic rotator cuff repair.
The overall purpose of the current study was to perform a detailed systematic review of the existing meta-analyses evaluating the role of PRP in patients undergoing rotator cuff repair; and to specifically provide answers to the following research questions, namely: (1) To evaluate the effect of this strategy on overall clinical outcome scores; (2) To evaluate the reduction in re-tear or failure rates; (3) To analyze the evolution and variations in the techniques of procurement and application of PRP across different studies; (4) To critically analyze and interpret the best currently available evidence and provide recommendations; and (5) To discern the major gaps in the existing literature and identify the scope for future research on this subject.
We then utilized the Jadad decision algorithm to identify the study with the highest quality to represent the current best evidence to generate the recommendation.
Recent meta-analyses are more supportive of the role of intra-operative administration of PRPs at the bone-tendon interface in improving the overall healing and re-tear rates, functional outcome and pain. The initial size of the tear and type of repair performed do not seem to affect the benefit of PRPs. Among the different preparations used, leucocyte poor (LP)-PRP possibly offers the greatest benefit as a biological augment in these situations.
Based on this systematic overview, we give a Level II recommendation that intra-operative use of PRPs at the bone-tendon interface can augment the healing rate, reduce re-tears, enhance functional outcome and mitigate pain in patients undergoing arthroscopic rotator cuff repair.
LP-PRP possibly offers the greatest benefit in terms of healing rates as compared with other platelet preparations.